Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
NEW YORK, Nov. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it collected a record-breaking 21,857 pounds of unused or expired medications during its eighth annual “Crush the Crisis” national prescription drug take back day. This marks the highest amount of medication collected in a single year since HCA Healthcare launched the annual event. Since launching “Crush the Crisis” as an enterprise-wide initiative in 2019,.
NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Commonwealth Equity Services LLC lowered its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 36.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,840 shares of the company's stock after selling 6,214 shares during
Fifth Third Bancorp lowered its stake in HCA Healthcare, Inc. (NYSE: HCA) by 7.1% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 31,954 shares of the company's stock after selling 2,452 shares during the period. Fifth Third Bancorp's
Eurizon Capital SGR S.p.A. reduced its position in HCA Healthcare, Inc. (NYSE: HCA) by 28.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,367 shares of the company's stock after selling 16,978 shares during the quarter.
I track 50 high-quality dividend growth stocks to identify favorable entry points, prioritizing long-term total return alongside a growing dividend stream. Forty stocks offer estimated future returns of at least 10%; 27 appear undervalued relative to historical free cash flow. ResMed leads with 41.60% estimated return potential; MarketAxess rose to fifth at 28.50% after a valuation upgrade and higher fair value estimate.